[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336293-105":59,"doc-detail-336293-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-significance-and-prospective-mechanism-of-increased-cdkn2a-expression-in-small-cell-lung-cancer","Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer","","Cyclin dependent kinase inhibitor 2A (CDKN2A) is implicated in multiple malignancies, yet its clinicopathological value and biological function in small cell lung cancer (SCLC) remain unclear. The study evaluates CDKN2A expression across SCLC using integrated high-throughput mRNA data, Kaplan–Meier survival analysis for prognostic significance, and protein validation by in-house immunohistochemistry. CDKN2A mRNA is markedly upregulated in 357 SCLC cases versus controls, correlating with poorer overall survival and supporting enhanced carcinogenesis and progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-significance-and-prospective-mechanism-of-increased-cdkn2a-expression-in-small-cell-lung-cancer/336293/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-significance-and-prospective-mechanism-of-increased-cdkn2a-expression-in-small-cell-lung-cancer/336293.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is CDKN2A studied in small cell lung cancer?","Question",{"text":112,"@type":113},"CDKN2A is known to play roles in several cancers, but its clinical and functional significance in SCLC is not well established, motivating further research.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CDKN2A’s clinical significance assessed?",{"text":117,"@type":113},"The clinical significance was examined using integrated high-throughput mRNA analysis, Kaplan–Meier survival analysis, and in-house immunohistochemistry for protein validation.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did CDKN2A expression show with patient outcomes?",{"text":121,"@type":113},"Higher CDKN2A expression was associated with worse overall survival, with reported hazard ratios greater than 1 across multiple datasets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336293,1790198281,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Clinical and Translational Oncology (2024) 26:1519–1531  \n[https://doi.org/10.1007/s12094-023-03376-2](https://doi.org/10.1007/s12094-023-03376-2)  \nClinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer  \nDong‑Ming Li1 · Guo‑Sheng Li2 · Jian‑Di Li1 · Feng Chen3 · Hong Huang4 · Wan‑Ying Huang1 · Zhi‑Guang Huang1 · Yi‑Wu Dang1 · Yu‑Lu Tang1 · Zhong‑Qing Tang5 · Wen‑Jia Tang1 · Gang Chen1 · Hui‑Ping Lu1  \nReceived: 12 July 2023 / Accepted: 14 December 2023 / Published online: 11 January 2024 © The Author(s) 2024  \nAbstract  \nBackground Although it has been shown that cyclin dependent kinase inhibitor 2A (CDKN2A) plays a significant role in a number of malignancies, its clinicopathological value and function in small cell lung cancer (SCLC) is unclear and warrants additional research.  \nMethods The clinical significance of CDKN2A expression in SCLC was examined by multiple methods, including comprehensive integration of mRNA level by high throughput data, Kaplan–Meier survival analysis for prognostic value, and validation of its protein expression using in-house immunohistochemistry.  \nResults The expression of CDKN2A mRNA in 357 cases of SCLC was evidently higher than that in the control group (n = 525) combing the data from 20 research centers worldwide. The standardized mean difference (SMD) was 3.07, and the area under the curve (AUC) of summary receiver operating characteristic curve (sROC) was 0.97 for the overexpression of CDKN2A. ACC, COAD, KICH, KIRC, PCPG, PRAD, UCEC, UVM patients with higher CDKN2A expression had considerably worse overall survival rates than those with lower CDKN2A expression with the hazard ratio (HR) > 1. Conclusion CDKN2A upregulation extensively enhances the carcinogenesis and progression of SCLC.  \nKeywords Cyclin dependent kinase inhibitor 2A · Small cell lung cancer · Clinical significance · Immunohistochemistry · Kaplan–Meier survival analysis  \n* Hui-Ping Lu[luhuiping@gxmu.edu.cn](luhuiping@gxmu.edu.cn)  \n1 Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China  \n2 Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China  \n3 Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China  \n4 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China  \n5 Department of Pathology, Wuzhou Gongren Hospital, The Seventh Affiliated Hospital of Guangxi Medical University, No.1, Nansanxiang Gaodi Road, Guangxi Zhuang Autonomous Region, Wuzhou 543000, People’s Republic of China  \nIntroduction  \nAccording to the Global Cancer Statistics 2020 report, with an expected 1.8 million fatalities, lung cancer continues tobe the top cause of cancer mortality globally [1–3] . Despite the fact that small cell lung cancer (SCLC) accounts for 15% of cases of lung cancer and non-small cell lung cancer (NSCLC) accounts for 85%[4], SCLCs is more aggressive, which have quicker metastasis and higher growth scores, and more than half of patients are diagnosed at an advanced stage [5]. With a five-year survival rate of\u003C 7%, SCLC is a malignant form of lung cancer that differs from NSCLC in that it has an extremely dismal prognosis. In addition, SCLCis very responsive to chemotherapy, but when it relapses, it has a very high recurrence rate and is nearly always resistant to therapy [6] . Therefore, further research is required to examine possible SCLC indicators and processes in order to develop a theoretical framework for the early detection, diagnosis, and treatment of SCLC.  \nOncogenes are often activated during the growth of tumors, whereas tumor suppressor genes are i","cbCaikQWc8Pq5u82","https://ap.wps.com/l/cbCaikQWc8Pq5u82","pdf",3802964,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why is CDKN2A studied in small cell lung cancer?\",\"answer\":\"CDKN2A is known to play roles in several cancers, but its clinical and functional significance in SCLC is not well established, motivating further research.\"},{\"question\":\"How was CDKN2A’s clinical significance assessed?\",\"answer\":\"The clinical significance was examined using integrated high-throughput mRNA analysis, Kaplan–Meier survival analysis, and in-house immunohistochemistry for protein validation.\"},{\"question\":\"What relationship did CDKN2A expression show with patient outcomes?\",\"answer\":\"Higher CDKN2A expression was associated with worse overall survival, with reported hazard ratios greater than 1 across multiple datasets.\"}]","Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer | PDF",1790014437,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb69443f456b666ebaad27d62efe6b7f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10ef9ecff91f014153d909003789844c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/464dda4a23df8b1f0a5c2c1358fbf786.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a465636b5df0221a01ad6bacf63f6d85.webp",980,1301]